• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

E-051 acute ischemic stroke due to tumorigenic embolism treated with mechanical thrombectomy
ConclusionIn acute stroke secondary to malignant tumorigenic embolism, mechanical thrombectomy might be a safe and effective treatment option.DisclosuresB. Bell: None. A. Saad: None. K. Layton: None. S. Shamim: None. G. Snipes: None. K. Hesselrode: None.
Source: Journal of NeuroInterventional Surgery - July 26, 2015 Category: Neurosurgery Authors: Bell, B., Saad, A., Layton, K., Shamim, S., Snipes, G., Hesselrode, K. Tags: SNIS 12th Annual Meeting Electronic Poster Abstracts Source Type: research

Sodium Tetradecyl Sulfate: A Review of Clinical Uses
CONCLUSION: Although not always the most effective method of treatment in off-label usage, use of STS has been frequently selected for a variety of applications for reasons of simplicity, low cost, lack of availability of technologically advanced equipment, and intricacies related to anatomic location.
Source: Dermatologic Surgery - October 28, 2017 Category: Dermatology Tags: Review Article Source Type: research

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases —a phase II study
ConclusionsPanitumumab and FOLFIRI as perioperative therapy for resectable CLM result in a radiological objective response rate in 65.7% of patients with a manageable grade 3 diarrhea rate of 14.3%. Median PFS was 13.2 months, and the 24-month OS rate was 73.3%. These data are insufficient to widen the indication of panitumumab from the unresectable setting to the setting of resectable CLM.
Source: Frontiers in Oncology - August 9, 2023 Category: Cancer & Oncology Source Type: research